Skip to main content
. 2020 Apr 24;13:107–113. doi: 10.2147/CEG.S243478

Table 1.

Clinical Variables and Risk Factors for Cardiovascular Disease in the IBD and Control Groups

IBD Group
(n=52)
Control Group
(n=37)
P-value
Age (y) 49.2±11.4 45.5±10.1 0.117
Sex, female 27 (51.9) 22 (59.4) 0.625
Active smoking 2 (3.8) 6 (16.2) 0.062
Diabetes 7 (13.5) 3 (8.1) 0.513
High blood pressure 8 (15.4) 6 (16.2) 0.850
Dyslipidemia 2 (3.8) 5 (13.5) 0.122
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
12 (11 - 13)
8 (7 - 9)
12 (11.5 - 13)
8 (7 - 8)
0.897
0.927
Total cholesterol (mg/dL) 188±43 195±37 0.434
HDL-cholesterol (mg/dL) 47.5 (39 - 59) 46 (41 - 53.5) 0.683
LDL-cholesterol (mg/dL) 108±37 119±27.6 0.136
Fasting glucose (mg/dL) 95 (86.2 - 107.3) 86 (79 - 100) 0.041
Triglycerides (mg/dL) 126.5 (89.5 - 181.5) 123 (89 - 182) 0.930
Carotid intima-media thickness (mm) 0.69±0.12 0.63±0.12 0.031
Presence of atherosclerotic plaque 13 (25) 2 (5.4) 0.032
Moderate and high cardiovascular risk according to the Framingham risk score 16 (30.8) 5 (13.5) 0.102

Note: Data expressed as n (%), mean±SD, or median and quartiles (Q1–Q3).

Abbreviations: HDL-cholesterol, high-density lipoprotein cholesterol; LDL-cholesterol, low-density lipoprotein cholesterol.